Feds: Hedge Fund Benefited From Insider Trading

Loading
Error

/

Download
Embed Code

Copy/paste the following code

Donate

Federal prosecutors filed another high-profile insider trading case Tuesday. A former hedge fund employee allegedly made $276 million for his fund after getting a sneak preview of clinical trial data for a new drug. The investigation may lead to even bigger cases.

Copyright 2016 NPR. To see more, visit http://www.npr.org/.

Copyright NPR. View this article on npr.org.